251 related articles for article (PubMed ID: 3156669)
21. Tumoricidal effector mechanisms of murine Bacillus Calmette-Guérin-activated macrophages: mediation of cytolysis, mitochondrial respiration inhibition, and release of intracellular iron by distinct mechanisms.
Klostergaard J; Leroux ME; Ezell SM; Kull FC
Cancer Res; 1987 Apr; 47(8):2014-9. PubMed ID: 3828989
[TBL] [Abstract][Full Text] [Related]
22. In vitro induction of cytotoxic polymorphonuclear leukocytes by supernatant from a concanavalin A-stimulated spleen cell culture.
Inoue T; Sendo F
J Immunol; 1983 Nov; 131(5):2508-14. PubMed ID: 6605388
[TBL] [Abstract][Full Text] [Related]
23. Calcium-independent induction of cytocidal activity of polymorphonuclear leukocytes by phorbol myristate acetate-like tumor promoters.
Morikawa K; Sato T; Nakazawa H; Fujita M
Life Sci; 1986 Mar; 38(12):1073-9. PubMed ID: 3083166
[TBL] [Abstract][Full Text] [Related]
24. Drug-dependent cellular cytotoxicity mediated by polymorphonuclear leukocytes.
Ikenami M; Mizuno D; Yamazaki M
Jpn J Cancer Res; 1985 Jul; 76(7):637-43. PubMed ID: 3928561
[TBL] [Abstract][Full Text] [Related]
25. Anti-tumor metastatic activity of beta-glucan purified from mutated Saccharomyces cerevisiae.
Yoon TJ; Kim TJ; Lee H; Shin KS; Yun YP; Moon WK; Kim DW; Lee KH
Int Immunopharmacol; 2008 Jan; 8(1):36-42. PubMed ID: 18068098
[TBL] [Abstract][Full Text] [Related]
26. The effect of beta-glucans on porcine leukocytes.
Sonck E; Stuyven E; Goddeeris B; Cox E
Vet Immunol Immunopathol; 2010 Jun; 135(3-4):199-207. PubMed ID: 20034677
[TBL] [Abstract][Full Text] [Related]
27. Particle digestibility is required for induction of the phosphatidylserine recognition mechanism used by murine macrophages to phagocytose apoptotic cells.
Fadok VA; Laszlo DJ; Noble PW; Weinstein L; Riches DW; Henson PM
J Immunol; 1993 Oct; 151(8):4274-85. PubMed ID: 8409401
[TBL] [Abstract][Full Text] [Related]
28. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
Brunda MJ; Taramelli D; Holden HT; Varesio L
J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
[TBL] [Abstract][Full Text] [Related]
29. Immunopharmacological studies of beta-1,3-glucan.
Ríos-Hernández M; Dos-Santos NJ; Silvia-Cardoso ; Bello-Gárciga JL; Pedroso M
Arch Med Res; 1994; 25(2):179-80. PubMed ID: 7919808
[TBL] [Abstract][Full Text] [Related]
30. beta(1 leads to 3) Glucan-mediated augmentation of alloreactive murine cytotoxic T-lymphocytes in vivo.
Hamuro J; Röllinghoff M; Wagner H
Cancer Res; 1978 Sep; 38(9):3080-5. PubMed ID: 150307
[TBL] [Abstract][Full Text] [Related]
31. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
32. Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies.
Kawase I; Komuta K; Ogura T; Fujiwara H; Hamaoka T; Kishimoto S
Cancer Res; 1985 Apr; 45(4):1663-8. PubMed ID: 3978634
[TBL] [Abstract][Full Text] [Related]
33. Effect of glucan and other adjuvants on the clearance of radiolabeled tumor cells from mouse lungs.
Proctor JW; Stiteler RD; Yamamura Y; Mansell PW; Winters R
Cancer Treat Rep; 1978 Nov; 62(11):1873-80. PubMed ID: 728905
[TBL] [Abstract][Full Text] [Related]
34. Induction of activated macrophages in C3H/HeJ mice by avirulent Salmonella.
Schafer R; Nacy CA; Eisenstein TK
J Immunol; 1988 Mar; 140(5):1638-44. PubMed ID: 3279120
[TBL] [Abstract][Full Text] [Related]
35. Activation of human polymorphonuclear leucocytes by particulate zymosan is related to both its major carbohydrate components: glucan and mannan.
Williams JD; Topley N; Alobaidi HM; Harber MJ
Immunology; 1986 May; 58(1):117-24. PubMed ID: 3710519
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan.
Patchen ML; Vaudrain T; Correira H; Martin T; Reese D
Exp Hematol; 1998 Dec; 26(13):1247-54. PubMed ID: 9845381
[TBL] [Abstract][Full Text] [Related]
37. Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes.
Schorlemmer HU; Bosslet K; Sedlacek HH
Cancer Res; 1983 Sep; 43(9):4148-53. PubMed ID: 6871856
[TBL] [Abstract][Full Text] [Related]
38. In vitro response of phagocytic cells to immunomodulating agents.
Stoika R; Kashchak N; Lutsik-Kordovsky M; Boyko M; Tsyrulnyk A
Med Sci Monit; 2001; 7(4):652-8. PubMed ID: 11433191
[TBL] [Abstract][Full Text] [Related]
39. Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents.
Germain RN; Williams RM; Benacerraf B
J Natl Cancer Inst; 1975 Mar; 54(3):709-20. PubMed ID: 1091741
[TBL] [Abstract][Full Text] [Related]
40. Antitumor and antimetastatic activity of a novel water-soluble low molecular weight beta-1, 3-D-glucan (branch beta-1,6) isolated from Aureobasidium pullulans 1A1 strain black yeast.
Kimura Y; Sumiyoshi M; Suzuki T; Sakanaka M
Anticancer Res; 2006; 26(6B):4131-41. PubMed ID: 17201124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
